Lucence aims to double revenue with Medicare coverage and lab partnership
Blood samples are processed and analyzed at Lucence’s laboratory in Singapore. (Photo by Kentaro Takeda)
KENTARO TAKEDA
December 16, 2025 10:43 JST
SINGAPORE — Lucence, a Singapore-based medical startup that offers cancer-testing services, is aiming to expand in the U.S. by leveraging coverage under the federal government’s Medicare insurance program and a recent partnership with a leading laboratory group.